Zivo Bioscience, Inc. Total Assets

Quick Answer Zivo Bioscience, Inc. reported Total Assets of $1.64 million for fiscal year 2024. Zivo Bioscience, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2024 $1.64M +195.7% 2023 $555.7K -73.8% 2022 $2.12M -76.4% 2021 $8.99M +3983.1% 2020 $220.2K -40.4% 2019 $369.4K -10.2% 2018 $411.5K +23.8% 2017 $332.3K -54.9% 2016 $737.3K … Read more

Zivo Bioscience, Inc. Diluted EPS

Quick Answer Zivo Bioscience, Inc. reported Diluted EPS of $4.23 per share (loss) for fiscal year 2024. Zivo Bioscience, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2024 -$4.23 +8.0% 2023 -$4.60 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September 30, 2025 -$0.27 +59.7% +37.2% June 30, 2025 … Read more

Zivo Bioscience, Inc. Net Income

Quick Answer Zivo Bioscience, Inc. reported Net Income of -$13.38 million for fiscal year 2024. Zivo Bioscience, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2024 -$13.38M -72.1% 2023 -$7.78M +11.1% 2022 -$8.75M +0.1% 2021 -$8.76M +3.8% 2020 -$9.11M +20.9% 2019 -$11.51M +21.4% 2018 -$14.64M -45.8% 2017 -$10.04M -65.7% 2016 -$6.06M … Read more

Zivo Bioscience, Inc. Revenue (ASC 606)

Quick Answer Zivo Bioscience, Inc. reported Revenue (ASC 606) of $157.2 thousand for fiscal year 2024. Zivo Bioscience, Inc. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2024 $157.2K +468.6% 2023 $27.6K — 2022 $0.00 — Quarterly Revenue (ASC 606) Quarter Ending Revenue (ASC 606) YoY QoQ September 30, 2025 … Read more

Zivo Bioscience, Inc. Total Revenue

Quick Answer Zivo Bioscience, Inc. reported Total Revenue of $157.2 thousand for fiscal year 2024. Zivo Bioscience, Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2024 $157.2K +468.6% 2023 $27.6K — 2022 $0.00 — 2021 $0.00 -100.0% 2020 $20.0K — 2019 $0.00 — 2018 $0.00 — 2017 $0.00 — 2016 $0.00 … Read more

Zivo Bioscience, Inc. Financial Summary

Quick Answer Zivo Bioscience, Inc. reported Total Revenue of $157.2 thousand for fiscal year 2024. Zivo Bioscience, Inc. — Key Financials by Year Metric 2024 2023 2022 2021 2020 2019 Total Revenue $157.2K+468.6% $27.6K $0.00 $0.00-100.0% $20.0K $0.00 Revenue (ASC 606) $157.2K+468.6% $27.6K $0.00 — — — Net Income -$13.38M-72.1% -$7.78M+11.1% -$8.75M+0.1% -$8.76M+3.8% -$9.11M+20.9% -$11.51M+21.4% … Read more

ZIPRECRUITER, INC. Shares Outstanding

Quick Answer ZIPRECRUITER, INC. reported Shares Outstanding of 71.37 million shares for fiscal year 2025. ZIPRECRUITER, INC. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 71.37M — The most recent figure is from ZIPRECRUITER, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026. All figures … Read more

ZIPRECRUITER, INC. Gross Profit

Quick Answer ZIPRECRUITER, INC. reported Gross Profit of $400.68 million for fiscal year 2025. ZIPRECRUITER, INC. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $400.68M -5.5% 2024 $423.85M -27.1% 2023 $581.41M -29.0% 2022 $818.35M +23.7% 2021 $661.53M +81.7% 2020 $363.98M -2.9% 2019 $374.78M — Quarterly Gross Profit Quarter Ending Gross Profit … Read more

ZIPRECRUITER, INC. Operating Income

Quick Answer ZIPRECRUITER, INC. reported Operating Income of -$19.36 million for fiscal year 2025. ZIPRECRUITER, INC. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$19.36M -1633.9% 2024 $1.26M -98.4% 2023 $79.44M -18.3% 2022 $97.23M +1258.6% 2021 -$8.39M -113.0% 2020 $64.43M +1119.8% 2019 -$6.32M — Quarterly Operating Income Quarter Ending Operating Income … Read more

ZIPRECRUITER, INC. R&D Expense

Quick Answer ZIPRECRUITER, INC. reported R&D Expense of $124.56 million for fiscal year 2025. ZIPRECRUITER, INC. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $124.56M -7.6% 2024 $134.83M -4.9% 2023 $141.80M +11.0% 2022 $127.74M +15.6% 2021 $110.47M +59.2% 2020 $69.41M +6.1% 2019 $65.41M — Quarterly R&D Expense Quarter Ending R&D Expense … Read more